Health Algernon Pharmaceuticals Announces Private Placement James Pereira Dec 13, 2023 VANCOUVER, British Columbia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT:… Read More...
Health Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with… James Pereira Jul 15, 2023 VANCOUVER, British Columbia, July 14, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT:… Read More...
Health Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT: The Spirit Molecule” to Join… James Pereira Oct 15, 2022 VANCOUVER, British Columbia, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or… Read More...
Health Algernon Pharmaceuticals Discloses Novel DMT Salt Patent Strategy Includes Bioactive Nicotinate and… James Pereira Jul 5, 2022 VANCOUVER, British Columbia, July 05, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or… Read More...
Health Algernon Pharmaceuticals Announces Completion of Enrollment in its Phase 2 Study of Ifenprodil for… James Pereira Feb 6, 2022 VANCOUVER, British Columbia, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or… Read More...
Health Algernon Pharmaceuticals Announces Effective Date of Previously Announced Share Consolidation James Pereira Nov 24, 2021 VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (“Algernon” or the… Read More...
Health Algernon Pharmaceuticals Files U.S. FDA Pre-IND Meeting Request for Ifenprodil Chronic Cough Phase 2… James Pereira Oct 9, 2021 VANCOUVER, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT:… Read More...